Affiliation:
1. 1Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
2. 2Department of Otorhinolaryngology-Head and Neck Surgery, Chung-Ang University, College of Medicine, Gwangmyeong Hospital, Seoul, Republic of Korea.
3. 3Department of Statistics and Actuarial Science, Soongsil University, Seoul, Republic of Korea.
Abstract
Abstract
Background:
Gamma-glutamyltransferase (GGT) is positively associated with several cancer types. The objective of this study was to investigate the association between GGT and head and neck cancer (HNC) incidence in a cohort of 10 million people, considering effects of smoking and alcohol consumption.
Methods:
All data used in this study were obtained from the Korean National Health Insurance Service database. We analyzed subjects who underwent health check-ups in 2009 and monitored them until 2018 (n = 9,597,952). Using proportional hazards models, quartiles of GGT as independent predictors for HNC incidence were evaluated.
Results:
The overall incidence of HNC increased in the highest quartile [r-GPT ≥ 40 U/L; HR, 1.452; 95% confidence interval (CI), 1.354–1.557]. Among HNC cases, the HR for hypopharyngeal cancer (HR, 2.364; 95% CI, 1.818–3.074) was significantly higher. HRs for HNC (larynx, sino-nasal, oropharynx, oral cavity, and nasopharynx, except salivary glands) were also significant.
Conclusions:
Elevated GGT was associated with the risk of some types of HNCs, such as hypopharyngeal, laryngeal, sinonasal, oropharyngeal, oral cavity, and nasopharyngeal cancer.
Impact:
Results of this study have implications for etiologic investigations and preventive strategies.
Funder
Korea Medical Device Development Fund
Publisher
American Association for Cancer Research (AACR)